Tandem Diabetes Care, Inc.
TNDM
$14.41
$0.070.49%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.03B | 1.01B | 1.01B | 1.00B | 982.95M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.03B | 1.01B | 1.01B | 1.00B | 982.95M |
| Cost of Revenue | 463.14M | 468.72M | 470.99M | 475.35M | 469.64M |
| Gross Profit | 564.40M | 546.01M | 536.01M | 526.37M | 513.31M |
| SG&A Expenses | 437.32M | 434.10M | 426.84M | 420.04M | 404.68M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.09B | 1.09B | 1.09B | 1.09B | 1.07B |
| Operating Income | -61.06M | -78.12M | -87.00M | -93.03M | -91.94M |
| Income Before Tax | -98.06M | -200.27M | -204.94M | -202.41M | -174.43M |
| Income Tax Expenses | -3.51M | 4.44M | -1.57M | 3.04M | 9.44M |
| Earnings from Continuing Operations | -94.55 | -204.71 | -203.37 | -205.45 | -183.87 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -94.55M | -204.71M | -203.37M | -205.45M | -183.87M |
| EBIT | -61.06M | -78.12M | -87.00M | -93.03M | -91.94M |
| EBITDA | -43.20M | -60.46M | -69.58M | -75.89M | -75.07M |
| EPS Basic | -1.40 | -3.07 | -3.05 | -3.09 | -2.78 |
| Normalized Basic EPS | -0.70 | -0.85 | -0.88 | -0.88 | -0.80 |
| EPS Diluted | -1.40 | -3.07 | -3.05 | -3.09 | -2.78 |
| Normalized Diluted EPS | -0.70 | -0.85 | -0.88 | -0.88 | -0.80 |
| Average Basic Shares Outstanding | 271.11M | 269.12M | 267.05M | 264.93M | 262.88M |
| Average Diluted Shares Outstanding | 271.11M | 269.12M | 267.26M | 265.15M | 263.09M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |